Compounds > stearylamine
Page last updated: 2024-08-21

stearylamine and Breast Neoplasms

stearylamine has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hu, FQ; Li, Y; Liu, X; Shang, XW; Wang, L; Yuan, H; Zhou, XQ1
Ghosh, PC; Kulshreshtha, R; Rajendran, V; Sharma, S1
Cui, J; Jiang, S; Li, Y; Liu, Z; Ma, L; Wang, Y; Yin, Q; Yu, H; Zhang, Z1

Other Studies

3 other study(ies) available for stearylamine and Breast Neoplasms

ArticleYear
Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment.
    Journal of Zhejiang University. Science. B, 2020, Volume: 21, Issue:3

    Topics: Amines; Antineoplastic Agents; Breast Neoplasms; Chitosan; Doxorubicin; Drug Delivery Systems; Epithelial-Mesenchymal Transition; Female; Humans; MCF-7 Cells; Neoplasm Metastasis; Oxidation-Reduction; rac1 GTP-Binding Protein; Reactive Oxygen Species; RNA, Small Interfering

2020
Enhanced efficacy of anti-miR-191 delivery through stearylamine liposome formulation for the treatment of breast cancer cells.
    International journal of pharmaceutics, 2017, Sep-15, Volume: 530, Issue:1-2

    Topics: Amines; Animals; Antagomirs; Breast Neoplasms; Cell Line, Tumor; Humans; Liposomes; Mice; MicroRNAs

2017
Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine.
    Molecular pharmaceutics, 2013, Jun-03, Volume: 10, Issue:6

    Topics: Amines; Animals; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Rats; Rats, Sprague-Dawley; Teniposide

2013